ILDS Newsletter No. 11/2010

Autor: X. Mirabel, F. Aubin, Naoki Oiso, Zhiying Cheng, Rosa Azevedo, Josep Malvehy, Lluís Puig, F. Laurent, Judit Daroczy, Hiromi Kobayashi, Olympia Bontems, M. Musiani, Catherine Ruffieux, V. Martinot, B. Balme, C. Lebbé, Rudolf Happle, Shaofang Xie, M. Thomas, Didac Barco, E. Berard, Annie Guerin, F. Agbalika, Marcello Niceta, G. Gallinella, A. Lévy, Ana Filipa Duarte, Florence Baudraz-Rosselet, Anne Pham-Ledard, Eva Vilarrasa, Haruyo Sayasa, Hisayoshi Imanishi, J. Roby, Marie Beylot-Barry, L. Mortier, Yoko Kano, M. Lafaurie, Shiraz R. Gupta, C. Castillo, Eric Rolland, N.E.C. Schartz, Ana Margarida Barros, C. Paul, M. Zerbini, Kees-Peter de Roos, Santi Fiorella, J. Kanitakis, Andrew P. Yu, Patricia Serrano, Osvaldo Correia, M. La Placa, E. Manaresi, G.A. Gentilomi, F. Bonvicini, Fan Yang, Raf Lijnen, J.C. Talmant, Rodney Juliet, Francisco Cuellar, Xiaolei Qin, R. Viraben, Parvez Mulani, E. Delaporte, Thomas Hunziker, René Goedkoop, Percy Hou Kang You, D. Nassar, Béatrice Vergier, Pedro Zaballos, T. Gheit, Tomohiko Narita, V. Lora, Michel Monod, Daisuke Tsuruta, J. Mazereeuw-Hautier, Tetsuo Shiohara, C. Livideanu, Eckart Haneke, D. Kerob, Marie-Sylvie Doutre, Susana Puig, Alfredo Caputo, M. Beylot-Barry, F. Fortenfant, N. Meyer, F. Piette, C. Bouché, Eric Q. Wu, Dominick Latremouille-Viau, Jean-Hilaire Saurat, Hiroshi Ikegami, Yanjun Bao, Agustín Alomar, S. Darras-Vercambre, E. Martin de Lassalle, Elisabeth Salsench, Akira Kawada, Valentina Caputo, C. Lavogiez, Yoshiko Mizukawa, Salvatrice Curiale, Massimo Lurati, P. Patenotre

Publikováno v: Dermatology. 220:189-192

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4bded6b726b93417097139d4f8d732ba
https://doi.org/10.1159/000284248

Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial

Autor: V, de Lastours, J, LeGoff, J, Brière, F, Agbalika, T, Boulet, Y, Lévy, F, Simon, J-P, Aboulker, J-M, Molina

Publikováno v: HIV medicine. 15(1)

Interleukin-2 (IL-2) therapy increased CD4 cell counts and delayed antiretroviral therapy (ART) initiation in HIV-infected patients in the Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) 119 trial. However, four cases of ly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9c0fca76c6de447334c6d7e61b1a4463
https://pubmed.ncbi.nlm.nih.gov/24299219

Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up

Autor: L, Verneuil, S, Gouarin, F, Comoz, F, Agbalika, C, Creveuil, M, Varna, A, Vabret, A, Janin, D, Leroy

Publikováno v: The British journal of dermatology. 163(1)

Hydroa vacciniforme (HV) is a chronic papulovesicular photodermatosis of childhood, with some cases persisting through adulthood. In children, the Epstein-Barr virus (EBV) has been detected in typical HV and in HV evolving into natural killer/T-cell

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2ffbfe0c5ce76dde352ac861eb49e805
https://pubmed.ncbi.nlm.nih.gov/20367637

Maladie de Kaposi et grossesse : quels risques pour la mère et son enfant ?

Autor: C. Pages, Martine Bagot, F. Brunet-Possenti, S. Uzan, F. Agbalika, C. Lebbé, Nicolas Dupin

Publikováno v: Annales de Dermatologie et de Vénéréologie. 138:A215-A216

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c7205364330739f015f85add058afe1c
https://doi.org/10.1016/j.annder.2011.10.222

Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF)

Autor: D, Farge, C, Lebbé, Z, Marjanovic, P, Tuppin, C, Mouquet, M N, Peraldi, P, Lang, C, Hiesse, C, Antoine, C, Legendre, J, Bedrossian, M F, Gagnadoux, C, Loirat, C, Pellet, J, Sheldon, J L, Golmard, F, Agbalika, T F, Schulz

Publikováno v: Transplantation. 67(9)

The exact reasons for the high incidence of Kaposi's sarcoma (KS) after kidney transplantation are still unknown. Immunosuppression is classically considered as the main risk factor, but the relative risk contributed by the patient's geographic origi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::26f346d8071ce9c125b4f3b8c6ca106c
https://pubmed.ncbi.nlm.nih.gov/10342315